Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
WGb-0301 in Idiopathic Inflammatory Myopathies: NCT07349823 Clinical Landscape Report 2026
18 September 2026
NCT07349823 clinical landscape for Idiopathic Inflammatory Myopathies: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
9 min read
Tirzepatide in Endometrioid intraepithelial neoplasia: NCT07349641 Clinical Landscape Report 2026
18 September 2026
NCT07349641 clinical landscape for Endometrioid intraepithelial neoplasia: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
Butylidenephthalide in Glioblastoma, IDH-Wildtype: NCT07349693 Clinical Landscape Report 2026
18 September 2026
NCT07349693 clinical landscape for Glioblastoma, IDH-Wildtype: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sacituzumab govitecan-hziy in Metastatic Triple-Negative Breast Carcinoma: NCT07359404 Clinical Landscape Report 2026
18 September 2026
NCT07359404 clinical landscape for Metastatic Triple-Negative Breast Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
Irinotecan Hydrochloride in Glioblastoma Multiforme: NCT07356973 Clinical Landscape Report 2026
18 September 2026
NCT07356973 clinical landscape for Glioblastoma Multiforme: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lactulose in Uveal Melanoma: NCT07354100 Clinical Landscape Report 2026
18 September 2026
NCT07354100 clinical landscape for Uveal Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Autologous CD19/BCMA Dual-Target CAR-T (Beijing Boren Hospital) in Idiopathic Inflammatory Myopathies: NCT07361094 Clinical Landscape Report 2026
18 September 2026
NCT07361094 clinical landscape for Idiopathic Inflammatory Myopathies: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
9 min read
IMSB-301 in Aicardi-Goutieres Syndrome: NCT07364513 Clinical Landscape Report 2026
18 September 2026
NCT07364513 clinical landscape for Aicardi-Goutieres Syndrome: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Anbalcabtagene autoleucel in Autoimmune Diseases: NCT07364396 Clinical Landscape Report 2026
18 September 2026
NCT07364396 clinical landscape for Autoimmune Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
KN-5501 in Systemic Lupus Erythematosus: NCT07358988 Clinical Landscape Report 2026
18 September 2026
NCT07358988 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
In vivo CAR-T drug based on LNP-mRNA targeting CD19(Xinqiao Hospital) in Purpura, Thrombocytopenic, Idiopathic: NCT07362758 Clinical Landscape Report 2026
18 September 2026
NCT07362758 clinical landscape for Purpura, Thrombocytopenic, Idiopathic: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Ciprocopan Succinate in Lupus Nephritis: NCT07363460 Clinical Landscape Report 2026
18 September 2026
NCT07363460 clinical landscape for Lupus Nephritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.